Starpharma Holdings (ASX:SPL) Days Payable : 5,266.62 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Starpharma Holdings Days Payable?

Starpharma Holdings's average Accounts Payable for the six months ended in Dec. 2023 was A$5.80 Mil. Starpharma Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.20 Mil. Hence, Starpharma Holdings's Days Payable for the six months ended in Dec. 2023 was 5,266.62.

The historical rank and industry rank for Starpharma Holdings's Days Payable or its related term are showing as below:

ASX:SPL' s Days Payable Range Over the Past 10 Years
Min: 885.74 Med: 2179.73 Max: 5177.62
Current: 2883.45

During the past 13 years, Starpharma Holdings's highest Days Payable was 5177.62. The lowest was 885.74. And the median was 2179.73.

ASX:SPL's Days Payable is ranked better than
90.66% of 717 companies
in the Biotechnology industry
Industry Median: 152.89 vs ASX:SPL: 2883.45

Starpharma Holdings's Days Payable increased from Dec. 2022 (2,293.54) to Dec. 2023 (5,266.62). It may suggest that Starpharma Holdings delayed paying its suppliers.

Starpharma Holdings Days Payable Historical Data

The historical data trend for Starpharma Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Days Payable Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

5,177.62

1,741.34

2,562.15

885.74

2,179.73

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															1,292.34	638.95	2,293.54	2,127.48	5,266.62

Competitive Comparison of Starpharma Holdings's Days Payable

For the Biotechnology subindustry, Starpharma Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Starpharma Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starpharma Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Starpharma Holdings's Days Payable falls into.

Starpharma Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Starpharma Holdings's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (6.762	+	6.615)	/	2 )	/	1.12	*	365
=	6.6885					/	1.12	*	365
=	2,179.73

Starpharma Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (6.615	+	4.986)	/	2 )	/	0.201	*	365 / 2
=	5.8005					/	0.201	*	365 / 2
=	5,266.62

Starpharma Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (ASX:SPL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (ASX:SPL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

SPHRY:USA SPHRF:USA PQ6:Germany

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings (ASX:SPL) Headlines

No Headlines